Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK DOI: 10.1016/j.eclinm.2026.104012
Overall survival for bevacizumab therapy in metastatic colorectal cancer: an updated analysis of the TRAVASTIN study DOI: 10.1016/j.clcc.2025.11.001
UpSMART: five years of digital innovation in cancer clinical research—achievements, challenges, and recommendations DOI: 10.3389/fdgth.2025.1708067
Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs DOI: 10.1016/j.ijmedinf.2025.105958
SylloBio-NLI: Evaluating Large Language Models on Biomedical Syllogistic Reasoning DOI: 10.18653/v1/2025.naacl-long.371
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors DOI: 10.1186/s12885-024-13073-0
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials DOI: 10.1177/03008916241248007
Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials DOI: 10.1200/CCI.22.00137